AstraZeneca PLC is 1.3x more valuable than GSK plc by market capitalization ($286.27 B vs $221.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GSK | AZN |
|---|---|---|
| Market cap | $221.53 B | $286.27 B |
| US-listed rank | #62 | #45 |
| SEC filings | 988 | 1,004 |
AstraZeneca PLC is 1.3x more valuable than GSK plc by market capitalization ($286.27 B vs $221.53 B).
Full pages: GSK plc and AstraZeneca PLC, or browse the full rankings.